INTT INTEST CORP
Instruments For Meas & Testing of Electricity & Elec Signals · NYSE · SEC CIK 1036262 · Fiscal year ends 12/31
Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.0%
TTM net income YoY85.0%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-1.0%
Net income 3-yr CAGR—
Margins
Gross margin43.4%
Operating margin-0.5%
Net margin-0.0%
FCF margin-3.0%
EBITDA margin2.8%
Returns
ROE-0.0%
ROA-0.0%
ROIC (approx.)-0.5%
Asset turnover0.81x
Leverage & solvency
Liabilities / assets30.8%
Debt / equity0.08x
Current ratio2.21x
Interest coverage-1.69x
Cash quality & payout
Operating cash flow / net income102.33x
Accruals ratio1.0%
Payout ratio—
Capex / revenue1.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $113.83M | $130.69M |
| Cost of revenue | $64.91M | $75.27M |
| Gross profit | $48.92M | $55.42M |
| R&D expense | $9.44M | $8.55M |
| SG&A expense | $22.23M | $23.56M |
| Operating income | -$3.73M | $3.39M |
| Interest expense | $450,000 | $846,000 |
| Pretax income | -$3.22M | $3.45M |
| Income tax | -$695,000 | $563,000 |
| Net income | -$2.53M | $2.89M |
| EBITDA | $3.07M | $8.79M |
| EPS (basic) | -0.21 | 0.24 |
| EPS (diluted) | -0.21 | 0.24 |
| Weighted avg. shares (diluted) | 12.20M | 12.24M |
| Balance sheet | ||
| Cash & equivalents | $14.22M | $19.83M |
| Receivables | $25.89M | $29.50M |
| Inventory | $31.58M | $26.84M |
| Current assets | $78.64M | $78.81M |
| PP&E, net | $4.78M | $4.46M |
| Goodwill | $32.36M | $30.74M |
| Intangibles | $24.88M | $26.38M |
| Total assets | $151.31M | $152.29M |
| Current liabilities | $35.76M | $31.95M |
| Short-term debt | $6.06M | $7.49M |
| Long-term debt | $1.41M | $7.54M |
| Total debt | $7.47M | $15.03M |
| Total liabilities | $47.69M | $52.50M |
| Shareholders' equity | $103.62M | $99.79M |
| Net debt | -$6.75M | -$4.80M |
| Shares outstanding | 12.49M | 12.38M |
| Cash flow statement | ||
| Operating cash flow | $7.32M | $3.82M |
| Capital expenditure | $1.63M | $1.32M |
| Free cash flow | $5.68M | $2.50M |
| Investing cash flow | -$1.63M | -$20.05M |
| Financing cash flow | -$8.22M | -$8.64M |
| Depreciation & amortization | $6.80M | $5.39M |
| Stock-based compensation | $1.61M | $1.86M |
| Share buybacks | $0 | $1.04M |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.